Scientific Presentations Highlight OGM's Utility for Cancer Research at Joint Annual Meeting for Three Molecular and Cytogenetic Associations

Core Insights - Bionano Laboratories will showcase optical genome mapping (OGM) at the 2024 joint annual meeting for ASCLS, AGT, and SAFMLS, highlighting its applications in hematological cancer research [7][13][14] - The company aims to transform genome analysis through OGM solutions, diagnostic services, and software, emphasizing its high sensitivity and resolution in detecting structural abnormalities [4][15] Company Overview - Bionano is a provider of genome analysis solutions, focusing on OGM to address complex biological and medical questions [4] - The company offers a comprehensive portfolio that includes OGM solutions for various research applications, alongside diagnostic testing services through its subsidiary, Lineagen, Inc. [4][16] Conference Details - The conference will take place from July 8-12, 2024, in Pittsburgh, Pennsylvania, featuring educational sessions on OGM's clinical utilities and implementation in cytogenetic laboratories [7][8] - Presentations will be led by experts from prominent medical institutions, including The University of Texas MD Anderson Cancer Center and Johns Hopkins University [13][14] Educational Sessions - Su Yang will present case studies demonstrating OGM's ability to detect pathogenic structural and copy number variants relevant to hematological cancer research [13] - Ying Zhou will discuss the clinical utilities of OGM in cytogenetic labs, while Wahab Khan will cover the setup and validation of OGM in laboratory settings [14][8]